Dimitrios Patsouras
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Dimitrios Patsouras has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alexis Schizas
Department of Colorectal Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK
2 shared publications - Mark L. George
Department of Colorectal Surgery, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
2 shared publications Alkiviadis Kostakis
Center of Experimental Surgery, Biomedical Research Foundation, Academy of Athens, Athens GR‑11527, Greece
1 shared publication- Anastasios Smirnis
12nd Propedeutic Department of Surgery, "Laiko" General Hospital, 17 Ag. Thoma str, 11527 Goudi, University of Athens, Medical School, Athens, Greece
1 shared publication Andreas C. Lazaris
1st Department of Pathology, Athens University Medical School, Athens GR‑11527, Greece
1 shared publication- Dimitrios Dimitroulis
Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
1 shared publication
Latest Publications
- 1 February 2016
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 31 (8) , 1499-1500
Hot pelvic exenteration: is it worth it?
- 1 February 2016
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 31 (8) , 1499-1500
Hot pelvic exenteration: is it worth it?
- 4 March 2015
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 30 (12) , 1735-1736
Novel application of anal fistula plug for the treatment of chronic anastomotic sinus
- 4 March 2015
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 30 (12) , 1735-1736
Novel application of anal fistula plug for the treatment of chronic anastomotic sinus
- 27 January 2015
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 11 (6) , 4585-4590
Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma
Fibroblast activation protein (FAP), a selective protein for tumor stromal fibroblasts, is expressed in >90% of human epithelial carcinomas. A characteristic feature of pancreatic cancer is an extensive fibrotic or desmoplastic reaction surrounding the primary tumor. The present study aimed to evaluate the expression levels of FAP and vascular endothelial growth factor (VEGF) and determine their correlation in pancreatic adenocarcinoma. Confocal laser scanning microscopy and conventional immunohistochemical analysis were used to quantify FAP and VEGF expression levels in formalin‑fixed and paraffin‑embedded tissue biopsies from 46 patients (male, 26; female, 20; mean age, 66 years; age range, 53‑80 years) with pancreatic adenocarcinoma stage IIA or IIB. The expression levels of FAP in the neoplastic and adjacent normal tissue were significantly higher in stage IIB patients, compared with stage IIA patients. FAP expression was correlated with positive lymph nodes, resulting in poor prognosis for stage IIB patients. The partial correlation coefficient between FAP and VEGF expression levels was 0.39 (P=0.007), and the two factors had an effect on patient survival. Multivariate analysis demonstrated the prognostic superiority of FAP over VEGF, which is considered to be the most consistently reproducible molecular marker with prognostic value in resected pancreatic adenocarcinoma. Due to the limited beneficial effect of current systemic therapies for pancreatic adenocarcinoma, targeting FAP may be a potential therapeutic strategy and requires further investigation.
- 27 January 2015
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 11 (6) , 4585-4590
Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma
Fibroblast activation protein (FAP), a selective protein for tumor stromal fibroblasts, is expressed in >90% of human epithelial carcinomas. A characteristic feature of pancreatic cancer is an extensive fibrotic or desmoplastic reaction surrounding the primary tumor. The present study aimed to evaluate the expression levels of FAP and vascular endothelial growth factor (VEGF) and determine their correlation in pancreatic adenocarcinoma. Confocal laser scanning microscopy and conventional immunohistochemical analysis were used to quantify FAP and VEGF expression levels in formalin‑fixed and paraffin‑embedded tissue biopsies from 46 patients (male, 26; female, 20; mean age, 66 years; age range, 53‑80 years) with pancreatic adenocarcinoma stage IIA or IIB. The expression levels of FAP in the neoplastic and adjacent normal tissue were significantly higher in stage IIB patients, compared with stage IIA patients. FAP expression was correlated with positive lymph nodes, resulting in poor prognosis for stage IIB patients. The partial correlation coefficient between FAP and VEGF expression levels was 0.39 (P=0.007), and the two factors had an effect on patient survival. Multivariate analysis demonstrated the prognostic superiority of FAP over VEGF, which is considered to be the most consistently reproducible molecular marker with prognostic value in resected pancreatic adenocarcinoma. Due to the limited beneficial effect of current systemic therapies for pancreatic adenocarcinoma, targeting FAP may be a potential therapeutic strategy and requires further investigation.
- Open Access
- 22 September 2011
- Published by Springer Nature in BMC Gastroenterology
- Vol. 11 (1) , 99
Giant pedunculated hepatocellular carcinoma with hemangioma mimicking intestinal obstruction
Pedunculated hepatocellular carcinoma (P-HCC) has rarely been reported and is characteristically large and encapsulated. Only sporadic cases have been published, in which P-HCC was combined with other liver tumors (mostly benign), making the diagnosis difficult.
- 22 September 2011
- Published by Springer Nature in BMC Gastroenterology
- Vol. 11 (1) , 99
Open AccessGiant pedunculated hepatocellular carcinoma with hemangioma mimicking intestinal obstruction
Pedunculated hepatocellular carcinoma (P-HCC) has rarely been reported and is characteristically large and encapsulated. Only sporadic cases have been published, in which P-HCC was combined with other liver tumors (mostly benign), making the diagnosis difficult.